CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
DNA damage response (DDR) and repair kinetics predict treatment response in patients receiving Lu-177-DOTA-TATE peptide receptor radionuclide therapy for advanced gastro-entero-pancreatic neuroendocrine tumors
DOI 10.1055/s-0040-1708134
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Derlin, N Bogdanova, F Ohlendorf, R Werner, H Christiansen, FM Bengel, C Henkenberens
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe02/2020
Jahrgang / SeitenJg. 59
Kernaussage aus der Literatur
Abstract-Vorschau
DNA damage response (DDR) and repair kinetics predict treatment response in patients receiving Lu-177-DOTA-TATE peptide receptor radionuclide therapy for advanced gastro-entero-pancreatic neuroendocrine tumors
Zitieren
Zitierempfehlung
T Derlin, N Bogdanova, F Ohlendorf, R Werner, H Christiansen, FM Bengel, C Henkenberens (2020) DNA damage response (DDR) and repair kinetics predict treatment response in patients receiving Lu-177-DOTA-TATE peptide receptor radionuclide therapy for advanced gastro-entero-pancreatic neuroendocrine tumors. Nuklearmedizin - NuclearMedicine, 59 (02). https://doi.org/10.1055/s-0040-1708134
Mit CareLit weiterarbeiten